Placental stem cells

Patent Number: 7,468,276

This patent covers stem cells obtained from the placenta, in some ways similar to Hariri's other patents in this area such as #7,255,879 Post-partum mammalian placenta, its use and placental stem cells therefrom and #7,311,905 Embryonic-like stem cells derived from post-partum mammalian placenta, and uses and methods of treatment using said cells.   

The patent essentially covers:  

"An isolated human placental stem cell that is OCT-4.sup.+ and CD34.sup.-, wherein OCT-4 is octamer binding protein 4, and wherein said placental stem cell has at least the following characteristics: CD10.sup.+, CD29.sup.+, CD44.sup.+, CD45.sup.-, CD54.sup.+, CD90.sup.+, SH3.sup.+, SH4.sup.+, SSEA3.sup.-, and SSEA4.sup.-"

"isolated human placental stem cell, wherein said placental stem cell is OCT-4.sup.+, CD34.sup.-, SSEA3.sup.- and SSEA4.sup.-" 

"An isolated human placental stem cell that is OCT-4.sup.+ and CD34.sup.+, and wherein said placental stem cell is SH3.sup.+ or SH4.sup.+"

These composition claims on the cell are accompanied by use claims, such as the ability of the cells to differentiate into neurons, bones, and cartilage.

View this patent on the USPTO website.